$107.89
1.151.08%
At close: -
$108.00
0.110.10%
After Hours: 7:52 PM EDT
Comments
Loading...
Gilead Sciences Insider Trading Activity | NASDAQ:GILD | Benzinga
Track the latest Gilead Sciences insider trading activity. Stay informed on recent buys, sells, and market impact for Gilead Sciences stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Gilead Sciences Inc Insiders Doing?
At Gilead Sciences Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.50K shares worth $276.33K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 16, 2025, Andrew D Dickinson, the company's CHIEF FINANCIAL OFFICER sold 2.5K shares for $91.35 each.
- On February 19, 2025, Andrew D Dickinson, the company's CHIEF FINANCIAL OFFICER sold 2.5K shares for $104.09 each.
- On March 18, 2025, Andrew D Dickinson, the company's CHIEF FINANCIAL OFFICER sold 2.5K shares for $110.53 each.
Ownership Statistics for Gilead Sciences Inc
Shares Outstanding
1.245B
Insider Shares Owned
8.623M
Insider Percentage Owned
0.69%
Institutional Shares Held
838.905M
Institutional Percentage Held
67.4%
| Mar 18, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -2.50K | $110.53 | -$276.32K | SELL | -1.44% | 170.67K | Mar 17 | View |
| Mar 12, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | 4.11K | $90.96 | -$1.42M | SELL-OPTIONS | 2.43% | 173.17K | Mar 10 | View |
| Feb 19, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -2.50K | $104.09 | -$260.23K | SELL | -1.46% | 169.06K | Feb 18 | View |
| Feb 13, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | 0.00 | $84.74 | -$4.81M | SELL-OPTIONS | 0.00% | 171.22K | Feb 12 | View |
| Feb 03, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | 0.00 | $82.37 | -$4.22M | SELL-OPTIONS | 0.00% | 129.87K | Jan 31 | View |
| Jan 16, 2025 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -2.50K | $91.35 | -$228.38K | SELL | -1.89% | 129.87K | Jan 15 | View |
| Dec 17, 2024 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -8.50K | $91.96 | -$781.66K | SELL | -6.03% | 132.37K | Dec 16 | View |
| Dec 03, 2024 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | 0.00 | $81.63 | -$5.54M | SELL-OPTIONS | 0.00% | 138.92K | Nov 29 | View |
| Nov 29, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -18.80K | $77.18 | -$6.01M | SELL | -18.87% | 80.80K | Nov 27 | View |
| Nov 27, 2024 | Jeffrey Bluestone | DIRECTOR | 3.21K | $76.32 | -$7.91K | SELL-OPTIONS | 56.27% | 8.92K | Nov 26 | View |
| Nov 07, 2024 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -5.00K | $91.28 | -$456.40K | SELL | -6.40% | 73.13K | Nov 06 | View |
| Nov 07, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -590.00 | $74.71 | -$893.49K | SELL | -0.59% | 99.60K | Nov 06 | View |
| Oct 02, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -2.00K | $83.83 | -$167.66K | SELL | -1.96% | 100.19K | Oct 01 | View |
| Sep 13, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | 3.75K | $71.21 | -$347.29K | SELL-OPTIONS | 3.81% | 102.19K | Sep 12 | View |
| Sep 13, 2024 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -29.36K | $83.78 | -$2.46M | SELL | -27.31% | 78.13K | Sep 12 | View |
| Aug 29, 2024 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -9.51K | $78.03 | -$742.30K | SELL | -8.27% | 105.47K | Aug 28 | View |
| Aug 14, 2024 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -5.49K | $73.98 | -$406.15K | SELL | -4.56% | 114.98K | Aug 13 | View |
| Jul 01, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -2.00K | $68.63 | -$137.26K | SELL | -2.03% | 96.38K | Jul 01 | View |
| Apr 02, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -2.00K | $72.96 | -$145.92K | SELL | -2.03% | 96.30K | Apr 01 | View |
| Feb 29, 2024 | Merdad Parsey | CHIEF MEDICAL OFFICER | -10.23K | $72.82 | -$744.98K | SELL | -9.94% | 92.71K | Feb 28 - Feb 29 | View |
| Jan 17, 2024 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -5.00K | $85.78 | -$428.90K | SELL | -4.69% | 101.53K | Jan 16 | View |
| Jan 10, 2024 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -8.24K | $85.23 | -$702.47K | SELL | -9.06% | 82.73K | Jan 09 | View |
| Oct 18, 2023 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -5.00K | $80.00 | -$400.02K | SELL | -4.59% | 104.00K | Oct 17 | View |
| Sep 13, 2023 | Merdad Parsey | CHIEF MEDICAL OFFICER | -1.50K | $76.99 | -$115.56K | SELL | -2.10% | 70.13K | Sep 12 | View |
| Jul 21, 2023 | Andrew D Dickinson | CHIEF FINANCIAL OFFICER | -5.00K | $80.00 | -$400.00K | SELL | -4.44% | 107.59K | Jul 20 | View |
| Jun 14, 2023 | Merdad Parsey | CHIEF MEDICAL OFFICER | -1.49K | $76.90 | -$114.20K | SELL | -4.81% | 29.40K | Jun 13 | View |
| Mar 14, 2023 | Merdad Parsey | CHIEF MEDICAL OFFICER | -6.13K | $78.99 | -$483.89K | SELL | -8.03% | 70.13K | Mar 13 | View |
| Mar 02, 2023 | Merdad Parsey | CHIEF MEDICAL OFFICER | -12.98K | $79.96 | -$1.04M | SELL | -15.62% | 70.13K | Mar 01 | View |
| Jan 03, 2023 | Merdad Parsey | CHIEF MEDICAL OFFICER | -553.00 | $85.33 | -$47.19K | SELL | -1.20% | 45.56K | Dec 30 | View |
| Nov 10, 2022 | Diane E Wilfong | SVP, CONTROLLER & CAO | 0.00 | $73.70 | -$125.69K | SELL-OPTIONS | 0.00% | 28.33K | Nov 09 | View |
| Nov 02, 2022 | Diane E Wilfong | SVP, CONTROLLER & CAO | 0.00 | $75.97 | -$106.47K | SELL-OPTIONS | 0.00% | 28.33K | Nov 01 | View |
| Mar 14, 2022 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | 0.00 | $58.12 | -$332.64K | SELL-OPTIONS | 0.00% | 32.58K | Mar 10 - Mar 11 | View |
| Feb 11, 2022 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | -1.69K | $63.89 | -$108.04K | SELL | -4.93% | 32.58K | Feb 09 | View |
| Feb 02, 2022 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | -14.06K | $68.54 | -$963.68K | SELL | -30.15% | 32.58K | Feb 01 | View |
| Aug 18, 2021 | Diane E Wilfong | SVP, CONTROLLER & CAO | 0.00 | $70.29 | -$60.19K | SELL-OPTIONS | 0.00% | 20.40K | Aug 17 | View |
| May 05, 2021 | Johanna Mercier | CHIEF COMMERCIAL OFFICER | -19.50K | $66.09 | -$1.29M | SELL | -70.73% | 8.07K | May 04 | View |
| May 04, 2021 | Richard J. Whitley | DIRECTOR | 0.00 | $42.61 | -$890.93K | SELL-OPTIONS | 0.00% | 31.12K | May 03 | View |
| Mar 12, 2021 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | 334.00 | $60.23 | -$145.91K | SELL-OPTIONS | 1.16% | 29.17K | Feb 15 - Mar 11 | View |
| Feb 11, 2021 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | -1.98K | $67.41 | -$133.13K | SELL | -6.41% | 28.83K | Feb 10 | View |
| Feb 03, 2021 | Brett A Pletcher | EVP,CORP AFFAIRS & GEN COUNSEL | -9.71K | $65.97 | -$640.63K | SELL | -25.20% | 28.83K | Feb 01 | View |
| Aug 19, 2020 | Merdad Parsey | — | 0.00 | $62.87 | -$1.98K | GRANT OR AWARD | 0.00% | 0.00 | Aug 15 - Aug 17 | View |
| Jun 25, 2020 | Javier Rodriguez | — | -189.00 | $75.50 | -$14.27K | SELL | -100.00% | 0.00 | Jun 23 | View |
| May 07, 2020 | Brett A Pletcher | — | 0.00 | $59.50 | -$521.41K | OPTION EXERCISE | 0.00% | 14.64K | May 05 | View |
| May 06, 2020 | Diane E Wilfong | — | -778.00 | $73.22 | -$220.01K | OPTION EXERCISE | -6.38% | 11.42K | May 04 | View |
| May 05, 2020 | John F. Cogan | — | 0.00 | $50.69 | -$150.08K | OPTION EXERCISE | 0.00% | 54.86K | May 04 | View |
| Apr 29, 2020 | John F. Cogan | — | 0.00 | $49.77 | -$145.43K | OPTION EXERCISE | 0.00% | 54.86K | Apr 27 | View |
| Apr 21, 2020 | John F. Cogan | — | 0.00 | $51.31 | -$152.91K | OPTION EXERCISE | 0.00% | 54.86K | Apr 20 | View |
| Apr 14, 2020 | John F. Cogan | — | 0.00 | $47.77 | -$135.78K | OPTION EXERCISE | 0.00% | 54.86K | Apr 13 | View |
| Apr 07, 2020 | John F. Cogan | — | 0.00 | $49.57 | -$144.51K | OPTION EXERCISE | 0.00% | 54.86K | Apr 06 | View |
| Mar 31, 2020 | John F. Cogan | — | 0.00 | $47.49 | -$134.45K | OPTION EXERCISE | 0.00% | 54.86K | Mar 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.